LBA Nordic Study: Low-Dose Aspirin Reduces Recurrence in Colorectal Cancer Patients with PI3K Pathway Mutations
Low-dose aspirin shows potential as a targeted, cost-effective treatment option to reduce cancer recurrence in colorectal cancer patients with specific PI3K pathway mutations, according to findings presented at the ASCO Gastrointestinal Cancers Symposium.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in